Le Lézard18h
SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO® alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms ...
The Lufkin Daily News2d
Drug-Free partnership luncheon set for Feb. 25
The Coalition is hosting its annual Drug-Free Business Partnership luncheon at 11:30 a.m. Tuesday, Feb. 25, at Crown Colony Country Club. The luncheon will acknowledge businesses in our community that ...
wusf2d
Red dye 3 is banned, but what products use it? Check the labels
The colorant was banned from cosmetics and non-oral medications years ago because a study showed it caused cancer in rats.
Kennedy’s Plan for the Drug Crisis: A Network of ‘Healing Farms’
The positions of Robert F. Kennedy Jr. on vaccines and drug companies are well known. His approach to addiction has been far ...